Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?

Autor:	Rosso KJ; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, FCT7.6092, Unit 1434, 1400 Pressler Street, Houston, Texas 77030-4008, USA., Weiss A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, FCT7.6092, Unit 1434, 1400 Pressler Street, Houston, Texas 77030-4008, USA., Thompson AM; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, FCT7.6092, Unit 1434, 1400 Pressler Street, Houston, Texas 77030-4008, USA. Electronic address: AThompson1@mdanderson.org.
Jazyk:	angličtina
Zdroj:	Surgical oncology clinics of North America [Surg Oncol Clin N Am] 2018 Jan; Vol. 27 (1), pp. 69-80.
DOI:	10.1016/j.soc.2017.08.002
Abstrakt:	The management of ductal carcinoma in situ (DCIS) has traditionally followed the evidence base for invasive breast cancer using surgery, radiation therapy, and drug therapy to remove the DCIS from the breast and reduce the risk of recurrence for both DCIS and invasive breast cancer. Because of concerns regarding the overtreatment of DCIS, randomized controlled trials have been established to test the outcomes (invasive breast cancer outcomes and patient-reported outcome measures) of active surveillance compared with guideline-concordant care for low-risk (for progression) DCIS. These strategies are undergoing rigorous evaluation to evaluate alternatives to the current management of DCIS. (Copyright © 2017 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu